GreenLight Biosciences Holdings's total assets for Q were $113.69M, a decrease of -23.49% from the previous quarter. GRNA total liabilities were $91.75M for the fiscal quarter, a -8.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.